Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion type Assertion NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_head.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion description "[The frequency of HLA-DR11 was increased in HCV carriers, compared with patients with end-stage liver disease (ESLD) (corrected P value [Pc],.0002) and, especially, with patients who had HCC (Pc=.003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_provenance.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion evidence source_evidence_literature NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_provenance.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion SIO_000772 14999597 NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_provenance.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion wasDerivedFrom befree-20150227 NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_provenance.
- NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_assertion wasGeneratedBy ECO_0000203 NP957558.RAhq0xFXbL9qwix4gcPLLVpVvXZ2QDyu5it_DRsAMOfIo130_provenance.